New Drug Enforcement Administration guideline for communicating controlled substance prescriptions to pharmacies

J Pain Palliat Care Pharmacother. 2011;25(1):83-9. doi: 10.3109/15360288.2011.566110.

Abstract

The Drug Enforcement Administration (DEA) is issuing this statement of policy to provide guidance under existing law regarding the proper role of a duly authorized agent of a DEA-registered individual practitioner in connection with the communication of a controlled substance prescription to a pharmacy.

Publication types

  • Guideline

MeSH terms

  • Communication
  • Drug Prescriptions*
  • Drug and Narcotic Control / legislation & jurisprudence*
  • Humans
  • Practice Patterns, Physicians'
  • Prescription Drugs / supply & distribution*
  • United States
  • United States Government Agencies

Substances

  • Prescription Drugs